New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

BioNTech and Pfizer Seek Covid-19 Booster Authorization

Updated boosters that combat Omicron variants could be available to the public in less than a month.

Screen Shot 2022 04 18 At 2 48 25 Pm

According to a recent CNN article, Pfizer and BioNTech have submitted applications asking the FDA to grant emergency use authorization to their updated COVID-19 vaccine. The formulation has been updated to combine the original vaccine with one tailored to kill Omicron variants BA.4 and BA.5. It is administered as a single 30 microgram dose intended for people age 12 and older.  

Preclinical data showed a “strong neutralizing antibody response” against the Omicron variants and the original strain. Clinical studies are expected to begin this month, but depending on the FDA’s response, the booster could be available to the public by early September.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub